Last updated: March 24, 2020
Sponsor: University of Bridgeport
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Cardiac Disease
Heart Defect
Heart Disease
Treatment
N/AClinical Study ID
NCT03953469
2019-02-01
All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: all University of Bridgeport students are invited to participate
Exclusion
Exclusion Criteria:
Those taking hypertensive medication
Those taking anti-anxiety medication, including MAOI medication
Those taking blood-thinning medication
Those who are pregnant
Those who could be pregnant
Those who will have surgery 2 weeks before the research date
Those who are scheduled to have surgery 2 weeks after the research date
Those who have consumed caffeine, food/tyramine containing foods, stimulantmedication, cold medicine, decongestant medicine, antihistamine medicine, coughsuppressants, alcoholic beverages, or stimulant energy drinks within 2 hours beforethe study period.
Study Design
Total Participants: 250
Study Start date:
August 01, 2020
Estimated Completion Date:
August 31, 2021